V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007087 | 290005412 | 1.58 | 51.3 | Neo-adjuvant (N) | 2014-12-22 | 2014-12-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 290022052 | CAPECITABINE + MITOMYCIN + RT |
| 290007088 | 290005413 | 1.51 | 54.1 | Not known (9) | 2014-09-25 | 2014-09-27 | FLUOROURACIL + MITOMYCIN | N | null | 290022063 | LANREOTIDE |
| 290007090 | 290005415 | 1.58 | null | Palliative (P) | 2017-12-16 | 2017-12-23 | Capecitabine + Cisplatin | N | N | 290022070 | CAPECITABINE + MITOMYCIN |
| 290007091 | 290005415 | 1.78 | 79.5 | null | null | 2013-12-31 | CARBOPLATIN + RT | null | null | 290022070 | SUNITINIB |
| 290007092 | 290005417 | null | 73 | Palliative (P) | null | 2015-01-12 | CARBOPLATIN + RT | N | N | 290022081 | ECX |
| 290007093 | 290005418 | 1.71 | 84.5 | Curative (C) | 2014-08-21 | 2014-10-06 | CARBOPLATIN + PACLITAXEL | 2 | N | 290022087 | CISPLATIN |
| 290007094 | 290005419 | 1.56 | 91 | Neo-adjuvant (N) | 2018-01-25 | 2018-01-26 | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 02 | Y | 290022087 | PERTUZUMAB + TRASTUZUMAB |
| 290007095 | 290005422 | null | null | Palliative (P) | 2016-10-14 | 2017-03-21 | Cisplatin 7 day | N | N | 290022099 | TRIFLURIDINE + TIPIRACIL |
| 290007096 | 290007297 | 1.62 | 78.9 | Neo-adjuvant (N) | 2016-12-19 | 2016-12-20 | NIVOLUMAB | N | N | 290022102 | CISPLATIN + FLUOROURACIL + RT |
| 290007097 | 290005423 | 1.52 | null | Curative (C) | 2015-03-10 | 2015-04-02 | CISPLATIN + FLUOROURACIL + RT | 2 | N | 290022106 | CAPECITABINE |
| 290007098 | 290005423 | 1.62 | null | Palliative (P) | 2018-09-13 | 2018-11-18 | Bevacizumab + CAPECITABINE + IRINOTECAN | N | N | 290022106 | PEMBROLIZUMAB |
| 290007099 | 290005425 | 1.7 | 45.9 | Curative (C) | null | 2018-02-22 | Capecitabine | N | Y | 290022118 | FLUOROURACIL + MITOMYCIN |
| 290007100 | 290005426 | 1.65 | 53.8 | Palliative (P) | 2018-07-18 | 2018-07-19 | Trial Unspecified | 02 | N | 290022128 | OCTREOTIDE |
| 290007101 | 290005427 | 1.8 | null | Curative (C) | 2018-03-01 | 2018-03-16 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 290022145 | CETUXIMAB |
| 290007102 | 290005428 | 1.81 | null | Palliative (P) | 2017-11-06 | 2017-12-04 | CVP R | 02 | N | 290022147 | INTERAACT TRIAL |
| 290007103 | 290005429 | 1.68 | 95 | Palliative (P) | null | 2018-06-29 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022147 | CAPECITABINE + OXALIPLATIN |
| 290007104 | 290008035 | 0 | null | null | 2014-04-05 | 2014-04-26 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | null | 290022153 | OCTREOTIDE |
| 290007105 | 290008035 | null | null | Palliative (P) | 2019-04-20 | 2019-04-20 | CETUXIMAB | null | Y | 290022153 | GEMCARBO |
| 290007106 | 290005430 | 1.56 | 48.9 | Palliative (P) | 2015-08-31 | 2015-10-13 | Bevacizumab + Irinotecan + MdG | 2 | N | 290022163 | CETUXIMAB |
| 290007107 | 290005431 | 1.8 | 77.7 | null | 2017-11-14 | 2017-11-21 | Sunitinib | 02 | N | 290022168 | LANREOTIDE |
| 290007108 | 290005431 | 1.77 | 60 | Curative (C) | 2013-12-06 | 2013-12-06 | Capecitabine + Oxaliplatin 21day | 02 | N | 290022168 | CISPLATIN + RT |
| 290007109 | 290005431 | 1.65 | 84.4 | Palliative (P) | 2016-07-16 | 2016-08-12 | Capecitabine + Cisplatin | 02 | N | 290022168 | CARBOPLATIN |
| 290007110 | 290005431 | 1.82 | 82 | null | 2015-06-12 | 2017-03-06 | Capecitabine 35days + RT | 2 | N | 290022168 | LANREOTIDE |
| 290007111 | 290008419 | 1.66 | 38.8 | Adjuvant (A) | 2016-01-19 | 2016-01-30 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 02 | N | 290022185 | CISPLATIN + RT |
| 290007112 | 290005432 | 1.71 | 113.6 | Curative (C) | 2018-04-07 | 2018-04-12 | Sunitinib | 02 | N | 290022192 | CISPLATIN + RT |
| 290007113 | 290007304 | 0 | 56.4 | null | 2016-01-01 | 2016-01-26 | CISPLATIN + RT | 02 | N | 290022197 | CAPECITABINE + OXALIPLATIN |
| 290007114 | 290005434 | 1.79 | null | Adjuvant (A) | 2017-10-15 | 2017-10-15 | Cisplatin 100 + RT(H&N) 1 day | N | null | 290022214 | CISPLATIN + RT |
| 290007115 | 290005438 | 1.79 | 108 | Palliative (P) | 2017-07-01 | 2017-07-01 | Carboplatin + Etoposide IV 3 day | 02 | N | 290022216 | CETUXIMAB |
| 290007116 | 290005439 | null | null | Palliative (P) | 2015-11-07 | 2015-11-14 | CARBOPLATIN + RT | N | N | 290022220 | OCTREOTIDE |
| 290007117 | 290005440 | 1.64 | 73.9 | Palliative (P) | 2018-08-22 | 2018-08-22 | CAPECITABINE + OXALIPLATIN | 02 | N | 290022222 | CAPECITABINE + OXALIPLATIN |
| 290007118 | 290005441 | 1.89 | 66.3 | Disease modification (D) | 2015-09-20 | 2015-09-23 | Cetuximab + FOLFIRI cycle1 | N | N | 290022227 | LANREOTIDE |
| 290007119 | 290005441 | 1.55 | 57.6 | Palliative (P) | 2014-03-20 | 2015-10-14 | Capecitabine + Oxaliplatin 21day | 02 | N | 290022227 | PACLITAXEL |
| 290007120 | 290005443 | null | 77.6 | Disease modification (D) | 2015-03-09 | 2015-03-16 | LANREOTIDE | N | N | 290022245 | CARBOPLATIN + PACLITAXEL |
| 290007121 | 290005443 | 1.6 | 65 | Adjuvant (A) | 2014-02-19 | 2014-03-05 | FLUOROURACIL + MITOMYCIN | N | N | 290022245 | BALLAD TRIAL |
| 290007122 | 290005443 | 1.65 | 71.3 | Palliative (P) | 2014-10-31 | 2014-11-07 | LANREOTIDE | N | N | 290022245 | PEMBROLIZUMAB |
| 290007123 | 290005443 | 1.68 | 38.8 | Palliative (P) | 2019-02-08 | 2019-02-08 | Cisplatin | N | N | 290022245 | OCTREOTIDE |
| 290007124 | 290005444 | 1.62 | null | Curative (C) | 2018-06-03 | 2018-06-07 | null | N | null | 290022251 | CISPLATIN |
| 290007125 | 290005445 | 1.78 | 69 | Curative (C) | 2017-10-10 | 2017-10-15 | CAPECITABINE + CISPLATIN + EPIRUBICIN | Y | N | 290022257 | ECX |
| 290007126 | 290005447 | null | 98.6 | Curative (C) | 2016-10-08 | 2016-10-18 | Cetuximab + CISPLATIN + FLUOROURACIL | N | Y | 290022260 | SUNITINIB |
| 290007127 | 290007307 | 1.58 | 61.1 | null | 2015-06-08 | 2015-08-23 | Irinotecan | N | N | 290022264 | CAPECITABINE + OXALIPLATIN |
| 290007128 | 290007307 | null | null | Curative (C) | 2016-09-02 | 2016-09-05 | CISPLATIN + FLUOROURACIL + RT | N | N | 290022264 | COMPARE TRIAL |
| 290007129 | 290007308 | 1.73 | 68.8 | Palliative (P) | 2015-10-13 | 2015-10-18 | INTERAACT trial | 2 | N | 290022278 | OCTREOTIDE |
| 290007130 | 290005452 | null | 44.8 | Adjuvant (A) | 2018-01-24 | 2018-02-19 | CARBOPLATIN + RT | null | null | 290022279 | CARBOPLATIN + RT |
| 290007131 | 290005453 | null | 88.4 | Palliative (P) | null | 2016-05-31 | Docetaxel + Nintedanib | N | null | 290022283 | CARBOPLATIN + CETUXIMAB + FU |
| 290007132 | 290005454 | 1.75 | 94.4 | null | 2017-10-06 | 2017-10-07 | Trial Unspecified | 02 | N | 290022286 | TRIAL |
| 290007133 | 290005456 | 1.84 | 87.9 | Curative (C) | 2018-11-19 | 2018-11-19 | LANREOTIDE | 2 | N | 290022289 | MITOMYCIN |
| 290007134 | 290005456 | null | null | Palliative (P) | 2017-12-25 | 2017-12-31 | PACLITAXEL | null | null | 290022289 | STREPTOZOCIN + MDG |
| 290007135 | 290005457 | 1.78 | null | Curative (C) | 2017-01-03 | 2017-03-12 | Capecitabine (14 day) + Irinotecan | N | Y | 290022294 | CAPECITABINE + RT |
| 290007136 | 290005458 | 0 | 87.15 | Palliative (P) | 2018-04-23 | 2018-04-23 | R IVAC | 02 | N | 290022295 | IRINOTECAN |
| 290007137 | 290005459 | null | null | Curative (C) | 2017-09-15 | 2017-10-26 | CARBOPLATIN + PACLITAXEL | 02 | N | 290022307 | CARBOPLATIN + RT |